Monday, August 06, 2018 8:46:41 PM
Always appreciate your perspectives.
I agree, but recent progress has challenged my confidence too. Still believe one can make a good return over the long run, but they're on close watch and a much shorter leash.
I want to see the value of "their bio-informatics and biosynthesis systems, and a strong drug pipeline". They've yet to clearly define it, imo....
GL
I agree, but recent progress has challenged my confidence too. Still believe one can make a good return over the long run, but they're on close watch and a much shorter leash.
I want to see the value of "their bio-informatics and biosynthesis systems, and a strong drug pipeline". They've yet to clearly define it, imo....
GL
Recent INM News
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
- InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM
- InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial • Newsfile • 03/09/2026 11:30:00 AM
- InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline • Newsfile • 03/06/2026 10:04:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:58:07 PM
- InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 02/11/2026 10:23:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 10:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 04:55:06 PM
- InMed Announces Results of 2025 Annual General and Special Meeting • Newsfile • 12/18/2025 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 05:20:20 PM
